تداخل‌های دارویی
Baricitinib + Idecabtagene vicleucel
شدت: شدید
Baricitinib and Idecabtagene vicleucel: major interaction.
آخرین به‌روزرسانی
ویژه کادر درمان — فقط جهت مرجع. این صفحه خلاصه‌ای کوتاه است، توصیه پزشکی نیست و جایگزین بروشور رسمی یا قضاوت بالینی نمی‌شود. پیش از تجویز یا تحویل دارو همیشه بررسی کنید.
محتوای بالینی این صفحه فقط به زبان انگلیسی موجود است.
خلاصه
Baricitinib may blunt the expansion and activity of CAR T cells, potentially reducing efficacy. Its immunosuppression also adds to the infection risk that already follows lymphodepletion and CAR T therapy.
معنای این تداخل به زبان ساده
Baricitinib and Idecabtagene vicleucel can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Baricitinib belongs to Musculoskeletal; Idecabtagene vicleucel belongs to Oncology.
چرا رخ می‌دهد
JAK inhibition suppresses T-cell and cytokine signaling, impairing CAR T-cell function and adding to immunosuppression.
اقدام لازم
Avoid baricitinib around leukapheresis and CAR T infusion unless clearly needed. If it is needed, coordinate with the treating oncology team and monitor for infection.
از داروساز چه بپرسید
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
ویژه اعضای Pro+
باز کردن کل صفحه
یک حساب بسازید و دوره آزمایشی Pro+ را شروع کنید تا توصیه‌های کامل مدیریت Baricitinib و Idecabtagene vicleucel، یادداشت‌های تکمیلی، جزئیات شواهد و بررسی‌کننده تداخل برای کل نسخه را باز کنید.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Pro+ را ۱۴ روز رایگان در وب امتحان کنید. بدون نیاز به کارت.
تداخلات دیگر Baricitinib
- Adenovirus types 4 and 7 live + Baricitinib منع مصرف
- Baricitinib + Bcg vaccine live منع مصرف
- Baricitinib + Tofacitinib منع مصرف
- Baricitinib + Upadacitinib منع مصرف
- Abatacept + Baricitinib شدید
- Adalimumab + Baricitinib شدید
تداخلات دیگر Idecabtagene vicleucel
پرسش‌های متداول
Can I take Baricitinib with Idecabtagene vicleucel?
MediHelp rates the interaction as major. Baricitinib and Idecabtagene vicleucel can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Baricitinib may blunt the expansion and activity of CAR T cells, potentially reducing efficacy. Its immunosuppression also adds to the infection risk that already follows lymphodepletion and CAR T therapy.
How serious is the interaction between Baricitinib and Idecabtagene vicleucel?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid baricitinib around leukapheresis and CAR T infusion unless clearly needed. If it is needed, coordinate with the treating oncology team and monitor for infection.
What other medicines interact with Baricitinib?
MediHelp also lists interactions of Baricitinib with, for example, Adenovirus types 4 and 7 live, Bcg vaccine live, Tofacitinib. The full list is on the Baricitinib page.
تک‌نگاری کامل، دوزاژ و بررسی تداخل دارویی در برنامه MediHelp
مرجع کامل را باز کنید، تداخل چند دارو را بررسی کنید و از ابزارهای دوز در برنامه MediHelp استفاده کنید.
